Alzheimer drug expected 2022

By Megan Brodie 3 years ago | In Companies, Products
  • 3 years ago

7 April 2021 Biogen is expected to submit its Alzheimer’s candidate aducanumab for PBS funding…

This is subscriber-only content. Please login to continue reading.